1. HBW Insight
  2. >>Beauty
  3. >>Business
  4. >>Deals

J&J Divests OTC Anti-Dandruff Product To Separate Buyers Across 3 Regions

 
• By Eileen Francis

J&J agrees to sell marketing rights to its OTC 1% ketoconazole dandruff treatment product to Kramer Labs in the US and Latin America, to German firm Stada in the EMEA and to UK firm Alliance Pharma for the Asia-Pacific market as it continues to spin off non-core brands and focus on its core $1bn brands.

Johnson & Johnson has three buyers in its latest consumer health product divestment. Rights to its 1% ketoconazole anti-dandruff shampoo, branded Nizatrol A-D in the US, are going to a separate firm for each of the US-Latin America, Asia-Pacific and Europe-Middle East-Africa regions.

J&J’s Belgian pharma division, Janssen Pharmaceutica NV, is selling US and Latin American rights to the formulation to Kramer Laboratories Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

US Beauty Deals: Kim Kardashian Buys Back Beauty Brand Rights From Coty, L’Oréal’s NYX Professional Makeup Teams With Warner Bros.

 
• By Eileen Francis

Kim Kardashian lifestyle company SKIMS buys back rights to SKKN by Kim from Coty, Inc., which had purchased a 20% interest in the brand in 2020 for $200m. Separately, NYX Professional Makeup partners with Warner Bros. to launch the “A Minecraft Movie” collection.

L’Oréal Sells ‘Pioneering’ Carol’s Daughter Hair Brand After 20-Year Ownership

 
• By Eileen Francis

L’Oréal USA has sold multi-cultural hair care brand Carol’s Daughter to an independent beauty entrepreneur with a ‘proven track record’ of acquiring and growing beauty brands, while it remains under the leadership of its founder and new President, Lisa Price.

Hungary’s Egis Picks Up Skin-Care Portfolio From Teva

 
• By Tom Gallen

Egis is the beneficiary as Teva again trims its OTC portfolio with the sale of Hungarian skin-care brand Neogranormon.

Alberto V05, Zest Among Iconic Brands Providing Platform For New Owner’s US Debut

 
• By Eileen Francis

Italian personal care and beauty manufacturer Sodalis Group will acquire Alberto V05, Zest soap, Sure deodorants and other personal care brands in a transaction with current owner Tengram Capital Partners expected to close by the end of October. Recent years have seen high private equity activity in cosmetics and personal care.

More from Business

Beiersdorf Repositioning In China Will Get Boost From Thiamidol Launch

 
• By Eileen Francis

Beiersdorf AG hit some initial bumps with a repositioning of its business in China, but the firm is optimistic about the rollout of Thiamidol Skin Care In 2026.

Revlon Names North American President As Shiseido America CEO Resigns; Beauty News Roundup

 
• By Eileen Francis

Revlon Group Holdings LLC announces Dana Medema, formerly VP and head of Personal Health in North America for Philips, will serve as president, North America. Separately, Shiseido Company, Ltd. reports Ron Gee has resigned as Americas Region CEO and will be replaced on an interim basis by Alberto Noe.

L’Oréal, LVMH On First Quarter Challenges

 
• By Eileen Francis

L’Oréal Groupe reports in a first quarter presentation that its US business was more challenging than anticipated, while China “was slightly less bad” and Europe represented the best growth contributor. Separately, LVMH's Sephora sees ‘less momentum’ in its US business as competitor Amazon takes an aggressive position on beauty pricing.